$8.50
0.050.59%
At close: -
$8.63
0.131.53%
After Hours: Dec 20, 4:33 PM EDT
Ocular Therapeutix reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ocular Therapeutix using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.22 | $-0.21 | -4.76 % |
Jun 2024 | 2024-08-07 | $-0.26 | $-0.22 | -18.2 % |
Mar 2024 | 2024-05-07 | $-0.28 | $-0.19 | -47.4 % |
Dec 2023 | 2024-03-11 | $-0.35 | $-0.30 | -16.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $15.43M | $17.14M | -10.0 % |
Jun 2024 | 2024-08-07 | $16.44M | $15.82M | 3.93 % |
Mar 2024 | 2024-05-07 | $14.77M | $15.41M | -4.13 % |
Dec 2023 | 2024-03-11 | $14.80M | $15.71M | -5.78 % |
Ocular Therapeutix (OCUL) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.22, which missed the estimate of $-0.21.
The Actual Revenue was $15.4M, which missed the estimate of $17.1M.
Browse earnings estimates, EPS, and revenue on all stocks.